AVENUE THERAP. DL-,0001

AVENUE THERAP. DL-,0001

Share · US05360L3042 · ATXI · A3DWU7 (XNMS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AVENUE THERAP. DL-,0001
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
No Price
28.04.2026 20:00
Current Prices from AVENUE THERAP. DL-,0001
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
ATXI
USD
28.04.2026 20:00
0,55 USD
-0,01 USD
-1,79 %
XNAS: NASDAQ
NASDAQ
ATXI
USD
28.04.2026 15:28
0,55 USD
-0,01 USD
-1,79 %
Share Float & Liquidity
Free Float 86,02 %
Shares Float 2,83 M
Shares Outstanding 3,29 M
Company Profile for AVENUE THERAP. DL-,0001 Share
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.

Company Data

Name AVENUE THERAP. DL-,0001
Company Avenue Therapeutics, Inc.
Symbol ATXI
Website https://www.avenuetx.com
Primary Exchange XNMS Frankfurt
WKN A3DWU7
ISIN US05360L3042
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Alexandra MacLean
Country United States of America
Currency EUR
Employees 0,0 T
Address 1140 Avenue of the America, 10036 New York City
IPO Date 2017-06-27

Stock Splits

Date Split
26.04.2024 1:75
23.09.2022 1:15

Ticker Symbols

Name Symbol
NASDAQ ATXI
More Shares
Investors who hold AVENUE THERAP. DL-,0001 also have the following shares in their portfolio:
Danske Invest Fjernøsten
Danske Invest Fjernøsten Share
RBC Quant Emerging Markets Equity Leaders ETF
RBC Quant Emerging Markets Equity Leaders ETF ETF